[86] documented that RG7834, a novel oral HBV gene expression inhibitor, could lessen the levels of viral proteins and reduce viremia. RG7834 is a small-molecule compound belonging into the dihydroquinolizinones chemical class similar to RNAi but through a special system. Also, this technique could inactivate the mutation of residual viral https://griffinvafkn.blogs100.com/28513556/indicators-on-etoposide-you-should-know